Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Applied Molecular Transport Inc (AMTI)

Applied Molecular Transport Inc (AMTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,872
  • Shares Outstanding, K 41,337
  • Annual Sales, $ 0 K
  • Annual Income, $ -126,330 K
  • EBIT $ -77 M
  • EBITDA $ -73 M
  • 60-Month Beta 2.28
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.64
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.90
  • Most Recent Earnings $-0.17 on 11/09/23
  • Next Earnings Date 11/13/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.51
  • Number of Estimates 1
  • High Estimate -0.51
  • Low Estimate -0.51
  • Prior Year -0.58
  • Growth Rate Est. (year over year) +12.07%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1600 +64.38%
on 12/13/23
0.3200 -17.81%
on 12/22/23
+0.0986 (+59.98%)
since 11/24/23
3-Month
0.1343 +95.83%
on 11/01/23
0.3200 -17.81%
on 12/22/23
+0.0870 (+49.43%)
since 09/26/23
52-Week
0.1343 +95.83%
on 11/01/23
0.8400 -68.69%
on 02/23/23
-0.1720 (-39.54%)
since 12/23/22

Most Recent Stories

More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMTI, ICPT, FNCB

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AMTI : 0.2630 (-14.30%)
ICPT : 19.00 (+0.21%)
FNCB : 6.75 (+5.30%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMTI, CHS, FNCB, ICPT

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AMTI : 0.2630 (-14.30%)
CHS : 7.59 (-0.13%)
FNCB : 6.75 (+5.30%)
ICPT : 19.00 (+0.21%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SPLK, ICPT, CHS, AMTI

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

SPLK : 156.90 (+0.25%)
ICPT : 19.00 (+0.21%)
CHS : 7.59 (-0.13%)
AMTI : 0.2630 (-14.30%)
Moore Kuehn Encourages AMTI, SPLK, ICPT, and CHS Investors to Contact Law Firm

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

AMTI : 0.2630 (-14.30%)
SPLK : 156.90 (+0.25%)
ICPT : 19.00 (+0.21%)
CHS : 7.59 (-0.13%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMTI, NEM, AEL, HCCI

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AMTI : 0.2630 (-14.30%)
NEM : 40.91 (-2.46%)
AEL : 56.47 (+0.55%)
HCCI : 45.51 (+0.09%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SPLK, CYTH, AMTI, EBC

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

SPLK : 156.90 (+0.25%)
CYTH : 0.6799 (+5.82%)
AMTI : 0.2630 (-14.30%)
EBC : 18.57 (-0.38%)
Pre-Market Brief: Stocks Climb As Recession Fears Ease, China Reopens Borders

March S&P 500 futures (ESH23) are trending up +0.72% this morning after three major U.S. benchmark indices closed higher on Friday as market participants digested a deluge of economic data against rate...

ESH23 : 3,957.05s (-0.09%)
ATNF : 2.38 (+6.73%)
AMC : 5.04 (+1.82%)
EC : 7.93 (-1.25%)
AMTI : 0.2630 (-14.30%)
PTRA : 0.0670 (-25.56%)
Applied Molecular Transport Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Announced positive top-line data for AMT-101 FILLMORE Phase 2 trial in chronic pouchitis Orphan indication with no FDA-approved productsCompany granted...

AMTI : 0.2630 (-14.30%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Applied Molecular Transport Inc. - AMTI

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Applied Molecular Transport Inc. ("Applied Molecular" or the "Company") (NYSE:...

AMTI : 0.2630 (-14.30%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Applied Molecular Transport Inc. - AMTI

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Applied Molecular Transport Inc. ("Applied Molecular" or the "Company") (NYSE:...

AMTI : 0.2630 (-14.30%)

Business Summary

Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company. It design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic and other diseases. The company's lead product candidate consist AMT-101, which is in clinical stage....

See More

Key Turning Points

3rd Resistance Point 0.3499
2nd Resistance Point 0.3315
1st Resistance Point 0.2972
Last Price 0.2630
1st Support Level 0.2445
2nd Support Level 0.2261
3rd Support Level 0.1918

See More

52-Week High 0.8400
Fibonacci 61.8% 0.5704
Fibonacci 50% 0.4871
Fibonacci 38.2% 0.4039
Last Price 0.2630
52-Week Low 0.1343

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar